126 related articles for article (PubMed ID: 6119869)
21. Inotropic effect of prenalterol in amitriptyline poisoning.
Heath A; Mårin P; Sjöstrand I
Intensive Care Med; 1984; 10(4):209-11. PubMed ID: 6147367
[TBL] [Abstract][Full Text] [Related]
22. Influence of heart rate on the effects of prenalterol on regional myocardial blood flow and function during coronary stenosis in dogs.
Berdeaux A; Bonhenry C; Duhazé P; Giudicelli JF; Thuillez C
Br J Pharmacol; 1984 Sep; 83(1):203-10. PubMed ID: 6148979
[TBL] [Abstract][Full Text] [Related]
23. Hemodynamic response to oral prenalterol in dilated decompensated cardiomyopathy as a result of cardiac and vascular effects.
Guazzi MD; Agostoni PG; Doria E; Loaldi A; Pepi M; Polese A
Angiology; 1985 Dec; 36(12):857-66. PubMed ID: 4083567
[TBL] [Abstract][Full Text] [Related]
24. Regional myocardial contractile response to the beta-adrenergic stimulant prenalterol in the conscious dog following myocardial infarction. Mechanism of hemodynamic effect.
Kirlin PC; Romson JL; Pitt B; Lucchesi B
Pharmacology; 1984; 28(1):51-60. PubMed ID: 6701187
[TBL] [Abstract][Full Text] [Related]
25. Hemodynamic effects of adrenergic stimulating and blocking agents in cardiogenic shock and low output state after myocardial infarction.
Misra SN; Kezdi P
Am J Cardiol; 1973 Jun; 31(6):724-35. PubMed ID: 4145230
[No Abstract] [Full Text] [Related]
26. Central and peripheral haemodynamic effects of prenalterol in patients with coronary heart disease.
Svendsen TL; Carlsen JE; Hartling OJ; Trap-Jensen J
Clin Physiol; 1981 Oct; 1(5):461-9. PubMed ID: 7199993
[TBL] [Abstract][Full Text] [Related]
27. Effects of prenalterol on cardiac performance and transmural myocardial perfusion in patients with chronic renal failure.
Pedersen T; Cleemann-Rasmussen K; Brynjolf I; Ording H; Nielsen PE; Rasmussen K
Eur J Clin Pharmacol; 1983; 25(3):287-92. PubMed ID: 6628515
[TBL] [Abstract][Full Text] [Related]
28. Circulatory response to prenalterol in normal subjects and in patients with primary congestive cardiomyopathy.
Guazzi MD; Qing LG; Olivari MT; Fiorentini C; Loaldi A; Bartorelli A; Moruzzi P; Polese A
Acta Med Scand Suppl; 1982; 659():233-50. PubMed ID: 6127892
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological and clinical effects of prenalterol--a new inotropic beta-adrenoceptor stimulant. Proceedings of a symposium in Hamburg, December 5, 1980.
Acta Med Scand Suppl; 1982; 659():1-325. PubMed ID: 6127881
[No Abstract] [Full Text] [Related]
30. Comparison of the vasodilator prazosin and the selective beta1 agonist prenalterol on rest and exercise haemodynamics in CHF.
Hutton I; Tweddel AC; Bastian BC; Murray RG
Acta Med Scand Suppl; 1981; 652():163-8. PubMed ID: 6120615
[No Abstract] [Full Text] [Related]
31. Intravenous prenalterol in acute and chronic heart failure.
Kirlin PC; Pitt B; Lucchesi BR
Acta Med Scand Suppl; 1982; 659():263-86. PubMed ID: 6127894
[No Abstract] [Full Text] [Related]
32. Haemodynamic and cardiac metabolic effects of the new beta 1 agonist prenalterol in patients with cardiac failure.
Kupper W; Schütt M; Hamm CW; Kuck KH; Hanrath P; Bleifeld W
Eur Heart J; 1983 Aug; 4(8):573-83. PubMed ID: 6139281
[TBL] [Abstract][Full Text] [Related]
33. Prenalterol in primary dilated cardiomyopathy: hemodynamic and angiographic evaluation.
Branzi A; Specchia S; Binetti G; Magelli C; Zannoli R; Magnani B
Eur Heart J; 1983 Apr; 4(4):252-8. PubMed ID: 6684041
[TBL] [Abstract][Full Text] [Related]
34. Prenalterol in the treatment of orthostatic hypotension in Shy-Drager syndrome.
Goovaerts J; Verfaillie C; Knockaert D; Fagard R; Fiocchi R; Amery A; Lijnen P
Acta Cardiol; 1984; 39(2):147-55. PubMed ID: 6145274
[TBL] [Abstract][Full Text] [Related]
35. Haemodynamic effects of intravenously administered prenalterol in patients with severe heart failure.
Waagstein F; Estrada-Yamamoto M; Reiz S; Reyes C; Hjalmarson A
Acta Med Scand Suppl; 1982; 659():221-31. PubMed ID: 6127891
[TBL] [Abstract][Full Text] [Related]
36. Effects of i.v. prenalterol in patients with severe cardiac failure at rest and during exercise.
Doering W; Wauer B; Isbary J
Acta Med Scand Suppl; 1982; 659():307-14. PubMed ID: 6127897
[TBL] [Abstract][Full Text] [Related]
37. [Hemodynamic effects of a new beta-1 stimulating drug (prenalterol) in acute myocardial infarct in the open-chest pig].
Branzi A; Binetti G; Specchia S; Magelli C; Zannoli R; Magnani B
Cardiologia; 1982; 27(1):33-43. PubMed ID: 6152732
[No Abstract] [Full Text] [Related]
38. Effect of isoproterenol,l-norepinephrine, and intraaortic counterpulsation on hemodynamics and myocardial metabolism in shock following acute myocardial infarction.
Mueller H; Ayres SM; Giannelli S; Conklin EF; Mazzara JT; Grace WJ
Circulation; 1972 Feb; 45(2):335-51. PubMed ID: 5009478
[No Abstract] [Full Text] [Related]
39. Selectivity of prenalterol for adrenergic receptor subtypes: a potential mechanism of inotropic selectivity.
Williams RS
J Cardiovasc Pharmacol; 1983; 5(2):266-71. PubMed ID: 6188901
[TBL] [Abstract][Full Text] [Related]
40. [Circulatory effects of prenalterol (a selective beta-1 agonist) in normal subjects and in patients with primary congestive cardiomyopathy].
Moruzzi P; Cipolla CM; Bartorelli A; Reggiani P; Ging LQ; Guazzi M
Cardiologia; 1982; 27(1):99-101. PubMed ID: 6152733
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]